Available Technologies

Browse Penn-owned technologies available for licensing.

HOME SEARCH RSS FEED

Search Results - christopher hunter

1 Results Sort By:
Novel biologics to treat T cell mediated inflammatory disease
Biologic therapeutic approach to modulating T cell inflammatory diseases by expressing isolated or recombinant combinations of WSX-1 or gp130 polypeptide with interacting proteins (such as p28, EBI3, Il-27) to inhibit pathological T cell development. ProblemThe interleukin-27 receptor (WSX -1) is a heterodimeric type I cytokine receptor for interle...
Published: 7/28/2015   |   Inventor(s): Christopher Hunter
Keywords(s):  
Category(s): Therapeutics & Vaccines